Ms CD279 (PD-1) BB700 J43 100ug产品图

Ms CD279 (PD-1) BB700 J43 100u

g
收藏
  • ¥5024
  • BD
  • 美国
  • 566514
  • 2026年10月23日
  • Flow Cytometry (FCM)
  • Armenian
  • Mouse
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商:

      BD Pharmingen

    • 靶点:

      CD279

    • 级别:

      RUO

    • 克隆性:

      单克隆

    • 抗原来源:

      Mouse

    • 抗体英文名:

      CD279 Antibody

    • 抗体名:

      CD279

    • 标记物:

      BB700

    • 宿主:

      Armenian

    • 适应物种:

      Mouse

    • 免疫原:

      Syrian Hamster kidney cell line BKH transfected with Pdcd1 cDNA

    • 亚型:

      Armenian Hamster IgG2, κ

    • 形态:

      液体

    • 应用范围:

      Flow Cytometry (FCM)

    • 保存条件:

      2-8℃避光保存

    • 规格:

      100 ug

    产品概述

    Ms CD279 (PD-1) BB700 J43 100ug 为 BD Pharmingen 品牌流式抗体,货号 566514,靶向 CD279,荧光标记 BB700,克隆 J43 (RUO),规格 100 ug。适用于 Flow cytometry (Routinely Tested) 检测,仅供科研使用(RUO)。

    靶点与抗体说明

    The J43 monoclonal antibody specifically recognizes CD279 which is also known as PD-1 (programmed death-1). CD279 is a 50-55-kDa glycoprotein encoded by the Pdcd1 gene of the CD28 family of the Ig superfamily. The expression of Pdcd1 mRNA and PD-1 protein is tightly regulated. PD-1 is transiently expressed on CD4-CD8 thymocytes, it is upregulated on some cell lines upon induction of apoptosis, it is induced on thymocytes and splenic T and B lymphocytes after stimulation through their antigen receptors, and it is induced on activated myeloid cells. In addition, Pdcd1 mRNA is transiently expressed in developing B lymphocytes at the pro-B-cell stage. The presence of an ITIM ( I mmunoreceptor T yrosine-based I nhibitory M otif) on PD-1's intracytoplasmic region and the development of splenomegaly and breakdown of peripheral tolerance in PD-1[-/-] mice suggest that PD-1 is involved in the negative regulation of immune responses. The PD-1 ligands, B7-H1 (also known as PD-L1, CD274) and B7-DC (PD-L2, CD273), are members of the B7 family of the Ig superfamily. The J43 antibody blocks the binding of PD-1 to its two ligands. The antibody was conjugated to BD Horizon BB700, which is part of the BD Horizon Brilliant™ Blue family of dyes.   It is a polymer-based tandem dye developed exclusive

    核心参数

    货号 566514
    品牌 BD Pharmingen
    克隆号 克隆 J43 (RUO)
    宿主 Armenian
    同种型 Armenian Hamster IgG2, κ
    荧光标记 BB700
    抗原 / 靶点 CD279
    反应种属 Mouse
    验证应用 Flow cytometry (Routinely Tested)
    免疫原 Syrian Hamster kidney cell line BKH transfected with Pdcd1 cDNA
    规格 100 ug
    存储缓冲液 Aqueous buffered solution containing ≤0.09% sodium azide.

    荧光染料信息

    BB700 The BD Horizon Brilliant™ Blue 700 (BB700) Dye is part of the BD Horizon Brilliant™ Blue family of dyes. This tandem fluorochrome is comprised of a polymer-technology dye donor with an excitation maximum (Ex Max) of 476-nm and an acceptor dye with an emission maximum (Em Max) at 695-nm. Driven by BD innovation, BB700 is designed to be excited by the blue laser (488-nm) and detected using an optical filter centered near 695-nm (e.g., a 695/20-nm bandpass filter). The donor dye can be excited by the Violet (405 nm) laser and the acceptor dye can be excited by the red (627–640 nm) laser resulting in cross-laser excitation and fluorescence spillover. BB700 Reagents are significantly brighter than equivalent PerCP or PerCP-Cy5.5 reagents and are less sensitive to photobleaching. In addition, BB700 shows much less excitation by the violet (407-nm) laser resulting in less spillover. BB700 has minimal yellow green (562-nm) excitation and is ideal for instruments with both blue (488-nm) and yellow green (562-nm) lasers. Please ensure that your instrument’s configurations (lasers and o

    保存与运输

    建议 2-8℃ 避光保存,请勿冷冻,避免反复冻融。 存储缓冲液:Aqueous buffered solution containing ≤0.09% sodium azide.

    参考文献

    Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol. 1996 May; 8(5):765-772. (Immunogen: Flow cytometry, Immunoprecipitation). Ansari MJ, Salama AD, Chitnis T, et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003 July; 198(1):63-69. (Clone-specific: Blocking). Carreno BM, Collins M. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol. 2002; 20:29-53. (Biology). Finger LR, Pu J, Wasserman R, et al. The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene. 1997 September; 197(1-2):177-187. (Biology). Nishimura H, Agata Y, Kawasaki A, et al. Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol. 1996 May; 8(5):773-780. (Clone-specific: Flow cytometry). Nishimura H, Minato N, Nakano T, Honjo T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol. 1998; 10(10):1563-1572. (Clone-specific: Flow cytometry). Salama AD, Chitnis T, Imitola J, et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med. 2003 July; 198(1):71-78. (Clone-specific: Blocking). Tsushima F, Iwai H, Otsuki N, et al. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol. 2003; 33(10):2773-2782. (Clone-specific).

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Nat Med:个体化肿瘤疫苗突破,特异性 T 细胞持续 4.5 年,患者存活率 100%

      性 T 细胞。 图片来源:Nature Medicine 那么,这些不同功能状态的特异性细胞亚群,其比例和状态在后期疫苗或 PD-1 单抗等治疗中是否发生了变化呢? 研究人员又对新抗原特异性 CD4+T 细胞的 TCR 谱系进行了分析。 进一步分析了这些患者的 T 细胞,发现这些患者体内不仅产生了靶向最初的目标新抗原的特异性 T 细胞,而且还扩展到识别其他与黑色素瘤相关的新抗原,起到了更强更持久的抗肿瘤效果。结果发现,在疫苗接种的启动阶段 (3 周、8 周和 12 周) 和加强阶段 (16 周、20

    • 人可溶性CD137(4-1BB)ELISA试剂盒 说明书

      人可溶性CD137 (4-1BB)ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 CD137/4-1BB/TNFRSF9 单抗包被于酶标板上,标准品和样品中的 4-1BB与单抗结合,加入生物素化的抗人 4-1BB ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入

    • PD-1受体及其配体的研究进展

      PD-1受体及其配体的研究进展关键词:PD-1;免疫受体;免疫耐受T细胞活化需要两个信号,第1信号来自T细胞抗原受体(TCR)与抗原肽-MHC复合物的结合,为抗原特异性的;第2信号即协同刺激信号,由T细胞上粘附分子的受体与抗原提呈细胞(APC)上相应的配体结合,为抗原非特异性的。第2信号在T细胞活化中具有重要的作用,若无协同刺激分子提供第2信号,T细胞识别抗原后将处于无应答状态或凋亡。CD28/CTLA-4与其配体B7-1、B7-2的结合为T细胞活化所必需的协同刺激通路,参与机体抗原特异

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥3168
    上海优宁维生物科技股份有限公司
    2026年10月23日询价
    ¥22
    艾美捷科技有限公司
    2025年07月08日询价
    询价
    广州东锐科技有限公司
    2026年09月28日询价
    ¥1100
    Proteintech中国公司
    2026年05月27日询价
    ¥2650
    武汉维克赛思科技有限公司
    2025年07月17日询价
    Ms CD279 (PD-1) BB700 J43 100ug
    ¥5024